FDA Approved: REPATHA — Original Application (Amgen USA Inc.)

View source ↗

Summary

FDA approved Repatha (evolocumab) from Amgen USA Inc. in an original application to lower LDL cholesterol in adults with familial hypercholesterolemia or athero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia

Drugs mentioned

• Repatha (Evolocumab)

Snippet

ORIG AP for REPATHA (EVOLOCUMAB)